Elutia Secures 2026 Great Place to Work Certification Amid High-Turnover Industry
Event summary
- Elutia Inc. earned 2026 Great Place to Work Certification, highlighting its high-trust workplace culture.
- Company reports median employee tenure of 6.3 years, with 54% of workforce and 62% of leadership roles held by women.
- Elutia's team includes 50% with advanced degrees and 33% with doctorates, reflecting deep scientific expertise.
- Boston Scientific acquired Elutia's EluPro™ product for $88 million, underscoring commercial validation.
The big picture
Elutia's certification comes as biotech firms increasingly prioritize workplace culture to attract and retain top talent in a competitive hiring landscape. The company's focus on gender diversity and scientific rigor aligns with broader industry shifts toward inclusive innovation. With Boston Scientific's acquisition of EluPro™ validating its commercial potential, Elutia's ability to balance purpose-driven culture with performance will be key to its long-term success.
What we're watching
- Talent Retention
- Whether Elutia can sustain its 6.3-year median tenure amid industry-wide talent wars.
- Commercial Execution
- How the $88 million EluPro™ deal will influence future product development and partnerships.
- Regulatory Agility
- The pace at which Elutia can navigate regulatory hurdles while maintaining its high-trust culture.
Related topics